1. Medtech Insight
  2. >>Device Area
  3. >>Diabetic Care

ATTD 2022: Mic Drop Moment As Medtronic Presents 780G Data Proving Closed Loop Ability

 
• By Barnaby Pickering

Results of the ADAPT study presented at the Advanced Technologies & Treatments for Diabetes conference in Barcelona support Medtronic’s hope that the 780g insulin pump will help to turn around its diabetes business or make it an attractive acquisition for another company.  

Medtronic's 780G insulin pump • Source: Medtronic

Initial results from the long-awaited ADAPT trial suggest Medtronic’s 780G insulin pump could represent a huge improvement for the management of diabetes.

ADAPT will be completed in July, but one of the trial’s investigators, Pratik Choudhary from King’s College London, presented preliminary results from ADAPT on 27 April at the International Conference on

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diabetic Care

More from Device Area